Cart
sales@molnova.com
Ivangustin
CAS No. 14164-59-1
Ivangustin( —— )
Catalog No. M31292 CAS No. 14164-59-1
Ivangustin exhibits remarkable cytotoxicity against HEp2, SGC-7901 and HCT116 human cancer cell lines.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 466 | In Stock |
|
| 5MG | 456 | In Stock |
|
| 10MG | 653 | In Stock |
|
| 25MG | 1026 | In Stock |
|
| 50MG | 1376 | In Stock |
|
| 100MG | 1851 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameIvangustin
-
NoteResearch use only, not for human use.
-
Brief DescriptionIvangustin exhibits remarkable cytotoxicity against HEp2, SGC-7901 and HCT116 human cancer cell lines.
-
DescriptionIvangustin exhibits remarkable cytotoxicity against HEp2, SGC-7901 and HCT116 human cancer cell lines.
-
In VitroIvangustin is against HeLa, PC-3, Hep-2, HepG2, CHO and HUVEC cells with IC50 of 3.2 μM, 4.5 μM, 3.3 μM, 5.2 μM, 6.4 μM, and 9.2 μM, respectively in a SRB colorimetric assay.
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
Recptor——
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number14164-59-1
-
Formula Weight248.3
-
Molecular FormulaC15H20O3
-
Purity>98% (HPLC)
-
Solubility——
-
SMILES——
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
(Pro30,Tyr32,Leu34)-...
(Pro30,Tyr32,Leu34)-Neuropeptide Y (28-36)
-
1H-Pyrrole-2-carboxy...
1H-Pyrrole-2-carboxylic acid, 4,5-dibromo-1-methyl- (1-methyl-4,5-dibromopyrrole-2-carboxylic acid) is a marine derived natural products found in Agelas flabelliformis.
-
RMC-6291
RMC-6291 is an orally active, covalent inhibitor of KRAS G12C (ON) that forms a tri-complex within tumor cells between KRAS G12C (ON) and cyclophilin A (CypA), thereby preventing KRAS G12C (ON) from signaling via steric blockade of RAS effector binding and eliciting deep and durable suppression of RAS pathway activity in KRAS G12C tumor models .
